Align Technology, Inc.
Align Technology, Inc. Q2 FY26 Results — Earnings Call Analysis
Q2 FY26 earnings call: what management said on revenue, margins and capex.
What the Q2 FY26 call signalled
3 of 4 strong
The short version
- Worldwide revenue growth for full-year 2026 is expected to be up 3% to 4% year-over-year. - The company expects 2026 worldwide revenue growth of 3% to 4% year-over-year.
From Align Technology, Inc.'s Q2 FY26 earnings-call transcript · updated 30 May 2026.
Revenue & Sales Performance
- Worldwide revenue growth for full-year 2026 is expected to be up 3% to 4% year-over-year.
- Q2 2026 revenues projected at $1.04 billion to $1.06 billion, a 3% to 5% increase year-over-year.
- Clear Aligner volume growth is anticipated to be mid-single digits for 2026.
- Clear Aligner volume expected to increase sequentially and year-over-year in Q2.
- Systems and Services revenues are predicted to grow sequentially in Q2 2026.
- Growth is broad-based across regions, patient segments, and channels.
- Strong momentum in Doctor Subscription Program with double-digit growth in Invisalign Touch-Up and retention products.
- Continued strength in teens/kids segment supported by Invisalign First and other products.
2 more points from Align Technology, Inc.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Align Technology, Inc. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capital expenditures for fiscal 2026 are expected to be $125 million to $150 million.
- These investments primarily relate to technology upgrades, additional manufacturing capacity, and maintenance.
- In Q1 2026, capital expenditures were $30.8 million, mainly for manufacturing capacity and facilities.
- Strategic investment focus includes advancing digital dentistry via the Align Digital Platform and scaling the iTero Lumina ecosystem.
- Expansion efforts are ongoing internationally with localized strategies.
2 more points from Align Technology, Inc.'s call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Align Technology, Inc. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Management expressed satisfaction with consistent double-digit growth in DSO (Dental Service Organization) groups driving strong conversion and patient growth.
- They highlighted efforts to activate retail doctors to operate more like DSOs to increase order volumes.
- The business remains cautiously optimistic with growth trends stable in North America and accelerating in international markets.
- Some prudence is baked into guidance due to macro uncertainties, including the ongoing Middle East situation impacting demand somewhat.
2 more points from Align Technology, Inc.'s call on order book
Create a free account to keep reading this call
Continue your research
Others in Health Care Equipment and Supplies this season
- Insulet Corporation (Q2 FY26)
Insulet Corporation Q2 FY26 quarterly results analysis. Full year 2026 total company revenue growth guidance raised to 21%-23%; Omnipod revenue growth of 22%-24
- Globus Medical, Inc. (Q2 FY26)
Globus Medical, Inc. Q2 FY26 quarterly results analysis. U.S. Market Cap $11,192, P/E 19.9. AI-powered earnings insights.
- Solventum Corporation (Q2 FY26)
Solventum Corporation Q2 FY26 quarterly results analysis. Expectation of improved growth in 2026 compared to 2025, supporting trajectory toward LRP targets (Pag
- Zimmer Biomet Holdings, Inc. (Q2 FY26)
Zimmer Biomet Holdings, Inc. Q2 FY26 quarterly results analysis. U.S. Market Cap $16,023, P/E 21.9. AI-powered earnings insights.
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Align Technology, Inc. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Align Technology, Inc. Q2 FY26 results?
- Worldwide revenue growth for full-year 2026 is expected to be up 3% to 4% year-over-year. - The company expects 2026 worldwide revenue growth of 3% to 4% year-over-year.
What is Align Technology, Inc. share price analysis?
Align Technology, Inc. currently shows a neutral. The stock trades at a P/E of 27.5 with a market cap of $12,408. Investors should review the full earnings analysis for detailed insights.
Is Align Technology, Inc. planning capital expenditure?
- Capital expenditures for fiscal 2026 are expected to be $125 million to $150 million.
Keep Align Technology, Inc. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.